Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,367 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06946927RecruitingPhase 1
Study of JMKX001899 with other drugs for advanced KRAS G12C lung cancer
This trial tests a new targeted therapy, JMKX001899, combined with other treatments for advanced non-small cell lung cancer that has a specific KRAS G12C mutation. It aims to see if this combination can help shrink tumors or slow cancer growth.
Guangzhou, GuangdongAges 18–75 - NCT06947473RecruitingPhase 1/Phase 2
CAR T-cell therapy for lupus, sclerosis, and Sjogren's
This trial tests a new type of immune cell therapy (CAR T-cells from umbilical cord blood) for people with certain autoimmune diseases that haven't responded to standard treatments. It aims to see if targeting two proteins (CD19 and BCMA) can help calm the overactive immune system.
Beijing, Beijing MunicipalityAges 6–65 - NCT06947707Recruiting
Blood thinners for brain blood clot in Chinese patients
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Beijing, Beijing MunicipalityAges 18–80 - NCT06949033RecruitingPhase 3
Cadonilimab with chemo for stomach cancer
This trial tests a new combination of immunotherapy (cadonilimab) and chemotherapy before and after surgery for a specific type of advanced stomach or gastroesophageal junction cancer. It aims to see if adding this immunotherapy helps shrink tumors and improve outcomes.
Lanzhou, GansuAges 18–75 - NCT06949150Recruiting
Combined heart CT scan study for coronary artery disease
This study tests a new way to use CT scans to look at both the structure of your heart arteries and how well blood flows through them. It may help doctors get a more complete picture of coronary artery disease without extra procedures.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06949891Recruiting
Keto diet for acromegaly
This trial tests if a ketogenic (very low-carb) diet can help lower IGF-I levels in people with acromegaly who are already on stable medication. If you have acromegaly and your IGF-I levels are still above normal despite treatment, this diet might offer an additional way to manage your condition.
RotterdamAges 18 years+ - NCT06949904RecruitingPhase 1/Phase 2
Melatonin as an add-on therapy for childhood pneumonia
This trial tests whether adding melatonin to standard pneumonia treatment helps children recover faster. It is for children aged 1 month to 12 years with pneumonia or severe pneumonia.
Islamabad, IslamabadAges 1 month–12 years - NCT06950034RecruitingPhase 1
Testing STX-0712 for advanced CMML or AML
This early-phase study tests a new drug called STX-0712 for people with certain types of blood cancers (CMML or AML) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink or control the cancer.
Stanford, CaliforniaAges 18 years+ - NCT06950437Recruiting
Brain stimulation therapy for language in children with autism
This trial tests a non-invasive brain stimulation method called aiTBS, guided by brain scans, to help improve language in children with autism spectrum disorder (ASD). It is for children aged 3 to 6.5 years who have language delays and speak Mandarin.
BeijingAges 3–6 - NCT06951672Recruiting
Testing a new mitral valve repair device
This trial tests a new device called AMEND™ that is placed through a vein in the leg to repair a leaky mitral valve without open-heart surgery. It is for people with significant mitral regurgitation who are at high risk for surgery.
Phoenix, ArizonaAges 21 years+ - NCT06953791RecruitingPhase 2
Comparing two treatments for Crohn's disease flare-ups
This trial compares a steroid called prednisolone to a special diet (aCDED with PEN) for treating Crohn's disease flare-ups. It aims to see which approach helps improve quality of life.
TübingenAges 18 years+ - NCT06954155RecruitingPhase 3
Tenecteplase for stroke treatment 24-72 hours after symptoms start
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
BeijingAges 18 years+ - NCT06954311Recruiting
Drug monitoring for children with IBD
This study monitors levels of certain medications (infliximab, adalimumab, vedolizumab, ustekinumab) in children with inflammatory bowel disease to see if adjusting the dose helps them feel better. It aims to improve treatment outcomes.
FeldkirchAges birth–18 years - NCT06954441RecruitingPhase 3
A new immune therapy for people with low IgG
This trial tests a new immunoglobulin treatment (V-Immune) for people with primary IgG deficiency who are already on IVIG therapy. It aims to see if this new therapy can effectively replace their current treatment.
Recife, PernanbucoAges 2 years+ - NCT06954623Recruiting
Partial breast re-irradiation for breast cancer recurrence
This trial tests a second round of radiation to just part of the breast for women who had a previous lumpectomy and radiation, and now have a small, early-stage cancer or DCIS in the same breast. The goal is to see if a focused re-treatment is safe and effective.
HeidelbergAges 18 years+ - NCT06954831RecruitingPhase 2
Short-course radiation for early-stage breast cancer
This trial tests a shorter, more intense radiation schedule for people with stage I-III breast cancer after lumpectomy. It aims to find if giving a higher daily dose over fewer sessions is safe and effective.
Arcadia, CaliforniaAges 40 years+ - NCT06955416RecruitingPhase 2/Phase 3
REAMBERIN for rehydration in diabetic ketoacidosis
This trial tests a solution called REAMBERIN to help rehydrate people with diabetic ketoacidosis (DKA). If you are 18–75 and have DKA with very high blood sugar and acidic blood, you may be able to join.
ArkhangelskAges 18–75 - NCT06956417Recruiting
Memory rehab after concussion
This trial tests a memory rehabilitation program for people who have had a concussion and still have memory problems. It uses a computer, tablet, or smartphone to help improve memory.
Calgary, AlbertaAges 18–59 - NCT06956664Recruiting
Exercise after steroid injection for herniated disc
This study tests whether adding a structured exercise program after a steroid injection for a herniated disc in the lower back helps reduce pain and improve function better than the injection alone. You may be eligible if you recently had the injection but still have significant pain.
ÇankırıAges 18–70 - NCT06956755Recruiting
Registry for MDS and treatment-related leukemia
This study collects information from people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that developed after cancer treatment. It does not test a new drug but helps doctors learn more about these conditions.
RouenAges 18 years+ - NCT06958588RecruitingPhase 4
PEMF therapy vs. leg compression for blood clot prevention in ICU
This trial is testing two different ways to prevent dangerous blood clots in ICU patients who cannot take blood-thinning medication. It compares a pulsed electromagnetic field device (PEMF) to a standard leg compression device. Both treatments are non-invasive and used without medication.
Belo Horizonte, BHAges Any age - NCT06960200RecruitingPhase 2
Phototherapy for sleep apnea when a mouthpiece didn't work
This study tests a light-based treatment (phototherapy) for people with sleep apnea who tried an oral mouthpiece but still have symptoms. The goal is to see if this therapy can offer relief when other options haven't worked fully.
EdmontonAges 18 years+ - NCT06961617RecruitingPhase 1
Immune cell therapy for advanced hepatitis B-related liver cancer
This trial tests a new immune cell therapy (LioCyx-M) for people with advanced liver cancer caused by hepatitis B. It uses specially designed T cells (a type of immune cell) that target the hepatitis B virus and may help fight the cancer.
BeijingAges 18–70 - NCT06961955RecruitingPhase 2
Shorter versus longer whole breast radiation for early-stage breast cancer
This trial compares a 5-day course of whole breast radiation plus a boost to the standard 9-day course for people with early-stage breast cancer who have certain risk factors, such as high-grade tumors or younger age. The goal is to see if the shorter treatment is just as safe and effective.
Salt Lake City, UtahAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,367 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.